Infection in Diabetes Mellitus Patients in China: Seroprevalence, Risk Factors, and Case-Control Studies

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2019 Jan 22

PMID 30662909

Citations 15

Authors

Yong-Xin Li

Hai Xin

Xiang-Yan Zhang

Cui-Ying Wei

Yu-He Duan

Hao-Fu Wang

Hai-Tao Niu

Affiliations

Soon will be listed here.

Abstract

The association between () infection and diabetes mellitus remains controversial. With the improvement of living standards, the prevalence rate of diabetes is steadily increasing in China. Thus, it is necessary to explore the possible association between toxoplasmosis and diabetes mellitus in China. Hence, case-control studies were conducted to explore the seroprevalence and identify the risk factors and possible transmission routes of infection in different types of diabetes, including type 1 diabetes (T1DM), type 2 diabetes (T2DM), and gestational diabetes (GDM) patients in China. Four hundred serum samples for each type of diabetes mellitus, matched with 400 control subjects for each group, were collected and examined for anti- IgG and IgM antibodies using commercially available enzyme immunoassay kits. The total seroprevalence in T1DM, T2DM, and GDM patients was 16.50%, 23.50%, and 21.25%, respectively. Each type of diabetes mellitus patients had a significantly higher seroprevalence than the control subjects. Multivariate regression identified three variables as risk factors for infection in diabetes patients, including keeping cats at home and consumption of raw oysters for T1DM patients and consumption of raw/undercooked meat and raw oysters for T2DM patients, which may help to guide future research and control policies in diabetes mellitus patients.

Citing Articles

Burden of intestinal parasites among diabetic patients in Africa: a systematic review and meta-analysis.

Debash M, Kumie G, Sisay A, Gedfie S, Abebe W, Ashagre A BMC Infect Dis. 2025; 25(1):54.

PMID: 39799295 PMC: 11724454. DOI: 10.1186/s12879-025-10441-4.

Deregulation of MicroRNA-146a and 155 expression levels might underlie complicated pregnancy in Toxoplasma Gondii seronegative women.

Naguib M, Zaher Y, Ali H, Elnoury H, Mohammed L, Habashy O BMC Womens Health. 2024; 24(1):416.

PMID: 39039506 PMC: 11265433. DOI: 10.1186/s12905-024-03233-6.

Seroepidemiology of in diabetic patients type 2 by enzyme-linked immunosorbent assay method in Zabol City, 2017-2018.

Dabirzadeh M, Sargazi M, Bagheri S J Res Med Sci. 2024; 29:19.

PMID: 38808216 PMC: 11132423. DOI: 10.4103/jrms.jrms_49_23.

Effects of and/or spiramycin as an adjunct in toxoplasmosis infection challenged with diabetes.

El Saftawy E, Turkistani S, Alghabban H, Albadawi E, Ibrahim B, Morsy S Food Waterborne Parasitol. 2023; 32:e00201.

PMID: 37719029 PMC: 10504688. DOI: 10.1016/j.fawpar.2023.e00201.

Type-1 diabetes mellitus down-regulated local cerebral glial fibrillary acidic protein expression in experimental toxoplasmosis.

Abdelhamid G, Abdelaal A, Shalaby M, Ahmed Fahmy M, Badawi M, Afife A J Parasit Dis. 2023; 47(2):319-328.

PMID: 37193484 PMC: 10182235. DOI: 10.1007/s12639-023-01573-y.

References

Joshi N, Caputo G, Weitekamp M, Karchmer A . Infections in patients with diabetes mellitus. N Engl J Med. 1999; 341(25):1906-12. DOI: 10.1056/NEJM199912163412507. View

Lindsay D, Collins M, Mitchell S, Cole R, Flick G, Wetch C . Sporulation and survival of Toxoplasma gondii oocysts in seawater. J Eukaryot Microbiol. 2004; 50 Suppl:687-8. DOI: 10.1111/j.1550-7408.2003.tb00688.x. View

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

Montoya J, Liesenfeld O . Toxoplasmosis. Lancet. 2004; 363(9425):1965-76. DOI: 10.1016/S0140-6736(04)16412-X. View

Dubey J . Toxoplasmosis - a waterborne zoonosis. Vet Parasitol. 2004; 126(1-2):57-72. DOI: 10.1016/j.vetpar.2004.09.005. View

Chen X, Wu B, Wang J, Bai T . [Mechanism of the protective effects of noninvasive limbs preconditioning on myocardial ischemia-reperfusion injury]. Chin Med J (Engl). 2005; 118(20):1723-7. View

Pradhan S, Yadav R, Mishra V . Toxoplasma meningoencephalitis in HIV-seronegative patients: clinical patterns, imaging features and treatment outcome. Trans R Soc Trop Med Hyg. 2006; 101(1):25-33. DOI: 10.1016/j.trstmh.2006.02.021. View

Shin D, Cha D, Hua Q, Cha G, Lee Y . Seroprevalence of Toxoplasma gondii infection and characteristics of seropositive patients in general hospitals in Daejeon, Korea. Korean J Parasitol. 2009; 47(2):125-30. PMC: 2688793. DOI: 10.3347/kjp.2009.47.2.125. View

Jones J, Dargelas V, Roberts J, Press C, Remington J, Montoya J . Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009; 49(6):878-84. DOI: 10.1086/605433. View

10.

Krause I, Anaya J, Fraser A, Barzilai O, Ram M, Abad V . Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members. Ann N Y Acad Sci. 2009; 1173:633-9. DOI: 10.1111/j.1749-6632.2009.04619.x. View

11.

Massie G, Ware M, Villegas E, Black M . Uptake and transmission of Toxoplasma gondii oocysts by migratory, filter-feeding fish. Vet Parasitol. 2010; 169(3-4):296-303. DOI: 10.1016/j.vetpar.2010.01.002. View

12.

Putignani L, Mancinelli L, Del Chierico F, Menichella D, Adlerstein D, Angelici M . Investigation of Toxoplasma gondii presence in farmed shellfish by nested-PCR and real-time PCR fluorescent amplicon generation assay (FLAG). Exp Parasitol. 2010; 127(2):409-17. DOI: 10.1016/j.exppara.2010.09.007. View

13.

Zhou P, Chen Z, Li H, Zheng H, He S, Lin R . Toxoplasma gondii infection in humans in China. Parasit Vectors. 2011; 4:165. PMC: 3174123. DOI: 10.1186/1756-3305-4-165. View

14.

Sullivan Jr W, Jeffers V . Mechanisms of Toxoplasma gondii persistence and latency. FEMS Microbiol Rev. 2011; 36(3):717-33. PMC: 3319474. DOI: 10.1111/j.1574-6976.2011.00305.x. View

15.

Jeon C, Haan M, Cheng C, Clayton E, Mayeda E, Miller J . Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care. 2012; 35(3):520-5. PMC: 3322696. DOI: 10.2337/dc11-1043. View

16.

Saadatnia G, Golkar M . A review on human toxoplasmosis. Scand J Infect Dis. 2012; 44(11):805-14. DOI: 10.3109/00365548.2012.693197. View

17.

Shirbazou S, Delpisheh A, Mokhetari R, Tavakoli G . Serologic Detection of Anti Toxoplasma gondii Infection in Diabetic Patients. Iran Red Crescent Med J. 2014; 15(8):701-3. PMC: 3918195. DOI: 10.5812/ircmj.5303. View

18.

Flegr J, Prandota J, Sovickova M, Israili Z . Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One. 2014; 9(3):e90203. PMC: 3963851. DOI: 10.1371/journal.pone.0090203. View

19.

Harker K, Ueno N, Lodoen M . Toxoplasma gondii dissemination: a parasite's journey through the infected host. Parasite Immunol. 2014; 37(3):141-9. DOI: 10.1111/pim.12163. View

20.

Drescher K, von Herrath M, Tracy S . Enteroviruses, hygiene and type 1 diabetes: toward a preventive vaccine. Rev Med Virol. 2014; 25(1):19-32. DOI: 10.1002/rmv.1815. View